An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol

NCT05874336 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH

Interventions

DRUG: Aramchol

Sponsor

Galmed Pharmaceuticals Ltd

Collaborators

[object Object]